Do you support this bill?

Assembly Bill A8932

2019-2020 Legislative Session

Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

2019-A8932 (ACTIVE) - Details

Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §2803-c, Pub Health L
Versions Introduced in Other Legislative Sessions:
2021-2022: A6628
2023-2024: A5218

2019-A8932 (ACTIVE) - Summary

Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication.

2019-A8932 (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8932
 
                           I N  A S S E M B L Y
 
                              January 2, 2020
                                ___________
 
 Introduced  by M. of A. BARCLAY -- read once and referred to the Commit-
   tee on Health
 
 AN ACT to amend the public health law, in  relation  to  designating  an
   individual  to  be  notified  in  the case of dose or brand change for
   psychotropic medication
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Subdivision 3 of section 2803-c of the public health law is
 amended by adding a new paragraph r to read as follows:
   R.  (I) PURSUANT TO REGULATIONS PROMULGATED BY THE COMMISSIONER, EVERY
 PATIENT SHALL HAVE THE RIGHT TO DESIGNATE AN INDIVIDUAL TO  BE  NOTIFIED
 IN  THE EVENT THAT THE FACILITY REDUCES THE DOSE OR CHANGES THE BRAND OR
 FORM OF THE PATIENT'S PSYCHOTROPIC MEDICATION. SUCH  NOTIFICATION  SHALL
 INCLUDE  A  WARNING LISTING POSSIBLE SIDE EFFECTS AND DRUG INTERACTIONS,
 INCLUDING SIDE EFFECTS UPON DISCONTINUATION OF SUCH DRUGS.  NOTIFICATION
 SHALL  BE  MADE  IN WRITING, AND SHALL NOT BE EFFECTIVE UNTIL RECEIPT OF
 THE WRITTEN CONSENT OF THE DESIGNATED INDIVIDUAL. IN THE CASE OF A GRAD-
 UAL DOSE REDUCTION, A DESIGNEE SHALL  CHECK  A  BOX  ACKNOWLEDGING  SUCH
 DESIGNEE  HAS BEEN GIVEN A COPY OF THE RIGHTS PERTAINING TO GRADUAL DOSE
 REDUCTIONS.
   (II) FOR THE PURPOSES OF  THIS  PARAGRAPH,  "PSYCHOTROPIC  MEDICATION"
 MEANS  A  MEDICATION  THAT  IS ADMINISTERED FOR THE PURPOSE OF AFFECTING
 BRAIN ACTIVITIES ASSOCIATED WITH MENTAL PROCESSES AND BEHAVIOR,  INCLUD-
 ING, BUT NOT LIMITED TO, ANTI-PSYCHOTICS, ANTI-DEPRESSANTS, ANXIOLYTICS,
 SEDATIVES AND HYPNOTICS.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law.
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD14049-03-9

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.